AN2 Therapeutics Inc (ANTX) Stock Price, Quote, News & History

ANTXNASDAQ
$4.83
N/A
At close: Sep 23, 5:00 PM EST
$4.96
0.132.69%
After Hours: Sep 22, 9:28 AM EST

AN2 Therapeutics (ANTX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-30.68M
Investing Cash Flow (TTM)
17.91M
Financing Cash Flow (TTM)
38.87M
Free Cash Flow (TTM)
-30.68M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
26.10M

Analyst Trends and Forecast

1
May
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$104.07M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.40
Earnings Yield % (TTM)
-21.72%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.01

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$44.32M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$4.86
Close
$4.83
Volume / Avg.
306.16K / 283.88K
Day Range
$4.67 - $4.95
52 Wk Range
1.00 - 7.19
Market Cap
$187.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
7.89%
Days to Cover
11.53

About

Sector
Health Care
Industry
Pharmaceuticals
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disea...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy AN2 Therapeutics (ANTX) stock?

A

You can purchase shares of AN2 Therapeutics (NASDAQ:ANTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AN2 Therapeutics (ANTX) competitors?

A

There are no as such competitors for AN2 Therapeutics.

Q

What is the forecast, or price target, for AN2 Therapeutics (ANTX) stock?

A

AN2 Therapeutics has a consensus price target of $5.40.

Q

What is the current price for AN2 Therapeutics (ANTX)?

A

The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $4.96 last updated September 22, 2026 at 9:28 AM EDT.

Q

Does AN2 Therapeutics (ANTX) pay a dividend?

A

There are no upcoming dividends for AN2 Therapeutics.

Q

When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?

A

AN2 Therapeutics does not have any upcoming earnings scheduled.

Q

Is AN2 Therapeutics (ANTX) going to split?

A

There is no upcoming split for AN2 Therapeutics.

Q

What sector and industry does AN2 Therapeutics (ANTX) operate in?

A

AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.